JP2016513970A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016513970A5 JP2016513970A5 JP2016501585A JP2016501585A JP2016513970A5 JP 2016513970 A5 JP2016513970 A5 JP 2016513970A5 JP 2016501585 A JP2016501585 A JP 2016501585A JP 2016501585 A JP2016501585 A JP 2016501585A JP 2016513970 A5 JP2016513970 A5 JP 2016513970A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nucleic acid
- dengue
- virus
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000007523 nucleic acids Chemical group 0.000 claims description 57
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 27
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 21
- 241000725619 Dengue virus Species 0.000 claims description 20
- 241000700605 Viruses Species 0.000 claims description 18
- 229920001184 polypeptide Polymers 0.000 claims description 17
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 17
- 230000002238 attenuated effect Effects 0.000 claims description 16
- 230000002163 immunogen Effects 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 230000028993 immune response Effects 0.000 claims description 6
- 230000001939 inductive effect Effects 0.000 claims description 6
- 229960005486 vaccine Drugs 0.000 claims description 6
- 241000710831 Flavivirus Species 0.000 claims description 3
- 241000710772 Yellow fever virus Species 0.000 claims description 2
- 229940051021 yellow-fever virus Drugs 0.000 claims description 2
- 208000001490 Dengue Diseases 0.000 claims 32
- 206010012310 Dengue fever Diseases 0.000 claims 32
- 208000025729 dengue disease Diseases 0.000 claims 32
- 108020004707 nucleic acids Proteins 0.000 claims 12
- 102000039446 nucleic acids Human genes 0.000 claims 12
- 239000002773 nucleotide Substances 0.000 claims 11
- 125000003729 nucleotide group Chemical group 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 239000000546 pharmaceutical excipient Substances 0.000 claims 8
- 241000894007 species Species 0.000 claims 5
- 241000710815 Dengue virus 2 Species 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 241000024188 Andala Species 0.000 claims 1
- 241000710829 Dengue virus group Species 0.000 claims 1
- 241000711549 Hepacivirus C Species 0.000 claims 1
- 241000710842 Japanese encephalitis virus Species 0.000 claims 1
- 241000710771 Tick-borne encephalitis virus Species 0.000 claims 1
- 241000710886 West Nile virus Species 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000035772 mutation Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 3
- 108090000944 RNA Helicases Proteins 0.000 description 2
- 102000004409 RNA Helicases Human genes 0.000 description 2
- 210000003501 vero cell Anatomy 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 102100029226 Cancer-related nucleoside-triphosphatase Human genes 0.000 description 1
- 241000282552 Chlorocebus aethiops Species 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 108010075285 Nucleoside-Triphosphatase Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 108700030379 flavivirus NS3 Proteins 0.000 description 1
- 230000009851 immunogenic response Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361800204P | 2013-03-15 | 2013-03-15 | |
| US61/800,204 | 2013-03-15 | ||
| PCT/US2014/024603 WO2014150939A2 (en) | 2013-03-15 | 2014-03-12 | Compositions and methods for dengue virus chimeric constructs in vaccines |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019105307A Division JP7050031B2 (ja) | 2013-03-15 | 2019-06-05 | ワクチンにおけるデングウイルスキメラおよび組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016513970A JP2016513970A (ja) | 2016-05-19 |
| JP2016513970A5 true JP2016513970A5 (cg-RX-API-DMAC7.html) | 2017-04-13 |
| JP6818548B2 JP6818548B2 (ja) | 2021-01-20 |
Family
ID=50678274
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016501585A Active JP6818548B2 (ja) | 2013-03-15 | 2014-03-12 | ワクチンにおけるデングウイルスキメラ構築物に関する組成物および方法 |
| JP2019105307A Active JP7050031B2 (ja) | 2013-03-15 | 2019-06-05 | ワクチンにおけるデングウイルスキメラおよび組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019105307A Active JP7050031B2 (ja) | 2013-03-15 | 2019-06-05 | ワクチンにおけるデングウイルスキメラおよび組成物 |
Country Status (32)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6818548B2 (ja) | 2013-03-15 | 2021-01-20 | タケダ ワクチン, インコーポレイテッドTakeda Vaccines, Inc. | ワクチンにおけるデングウイルスキメラ構築物に関する組成物および方法 |
| US10004795B2 (en) * | 2015-09-08 | 2018-06-26 | Fundacao Butantan | Process for preparing an attenuated tetravalent dengue vaccine |
| KR102297300B1 (ko) * | 2015-11-27 | 2021-09-02 | 케이엠 바이올로직스 가부시키가이샤 | 뎅기 바이러스 약독주를 뱅크화한 생바이러스, 및 그것들을 항원으로 하는 뎅기 백신 |
| KR102611235B1 (ko) * | 2016-04-13 | 2023-12-08 | 다케다 백신즈 인코포레이티드 | 어린이 및 젊은 성인에서 뎅기 바이러스에 대한 백신접종 조성물 및 방법 |
| US11426461B2 (en) | 2018-09-05 | 2022-08-30 | Takeda Vaccines, Inc. | Methods for preventing dengue and hepatitis A |
| PE20211545A1 (es) | 2018-09-05 | 2021-08-16 | Takeda Vaccines Inc | Dosis unitaria de vacuna contra el dengue y administracion de esta |
| US11464815B2 (en) | 2018-09-05 | 2022-10-11 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
| US20240076631A2 (en) | 2020-02-27 | 2024-03-07 | Takeda Vaccines, Inc. | Method for removing host cell dna from virus preparation |
| WO2021173597A1 (en) * | 2020-02-28 | 2021-09-02 | Merck Sharp & Dohme Corp. | Dengue serotype specific rt-pcr multiplex assay |
| EP3892737A1 (en) * | 2020-04-09 | 2021-10-13 | Takeda Vaccines, Inc. | Qualitative and quantitative determination of single virus haplotypes in complex samples |
| WO2023147337A2 (en) | 2022-01-25 | 2023-08-03 | Takeda Vaccines, Inc. | Large-scale flaviviral vaccine production and manufacture |
| US20250177511A1 (en) | 2022-02-15 | 2025-06-05 | Takeda Vaccines, Inc. | Dengue vaccine batch mixing process |
| WO2023215383A1 (en) | 2022-05-04 | 2023-11-09 | Takeda Vaccines, Inc. | Computer-based determination of flavivirus infectivity |
| WO2024086681A1 (en) * | 2022-10-20 | 2024-04-25 | Takeda Vaccines, Inc. | A method for detecting the presence of a dengue virus serotype in a sample containing at least one dengue virus serotype |
| EP4375381A1 (en) | 2022-11-18 | 2024-05-29 | Takeda Vaccines, Inc. | A method for determining the proportion of a live, attenuated flavivirus having a nucleotide sequence comprising at least one attenuation locus in a formulation |
| WO2024118740A1 (en) | 2022-11-29 | 2024-06-06 | Takeda Vaccines, Inc. | Large-scale flaviviral vaccine production and manufacture |
| WO2025122855A1 (en) | 2023-12-08 | 2025-06-12 | Takeda Vaccines, Inc. | A method for determining the concentration of residual vero cell genomic dna in a sample containing virus obtained from production in vero cells |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5276941A (en) | 1975-12-23 | 1977-06-28 | Ito Masato | Method of conversing infrared rays |
| US4810092A (en) | 1986-02-21 | 1989-03-07 | Midac Corporation | Economical spectrometer unit having simplified structure |
| JPH0768267B2 (ja) | 1986-06-05 | 1995-07-26 | 財団法人阪大微生物病研究会 | フラビウイルス抗原 |
| JPH084508B2 (ja) | 1987-09-16 | 1996-01-24 | 国立予防衛生研究所長 | 組み換えワクチニアウイルス |
| JP2511494B2 (ja) | 1988-05-12 | 1996-06-26 | 善治 松浦 | 日本脳炎ウイルス表面抗原蛋白質の製造法 |
| US6184024B1 (en) | 1988-07-14 | 2001-02-06 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric and/or growth-restricted flaviviruses |
| IL91304A0 (en) | 1988-08-20 | 1990-03-19 | Us Health | Recombinant vaccinia virus for prevention of disease caused by flavivirus |
| US5514375A (en) | 1990-08-15 | 1996-05-07 | Virogenetics Corporation | Flavivirus recombinant poxvirus vaccine |
| MY109299A (en) | 1990-08-15 | 1996-12-31 | Virogenetics Corp | Recombinant pox virus encoding flaviviral structural proteins |
| US5494671A (en) | 1990-08-27 | 1996-02-27 | The United States Of America As Represented By The Department Of Health And Human Services | C-terminally truncated dengue and Japanese encephalitis virus envelope proteins |
| ES2140418T3 (es) | 1991-09-19 | 2000-03-01 | Us Health | Flavivirus quimericos y/o flavivirus de crecimiento restringido. |
| JPH05276941A (ja) | 1992-02-28 | 1993-10-26 | Nippon Zeon Co Ltd | フラビウイルス科に属するウイルスの表面抗原タンパク質を含む非感染性の構造物粒子の製造方法 |
| ES2184869T3 (es) | 1995-05-24 | 2003-04-16 | Hawaii Biotech Group | Vacuna sub-unitaria contra la infeccion por flavivirus. |
| WO1996040933A1 (en) * | 1995-06-07 | 1996-12-19 | The Government Of The United States Of America, Represented By The Secretary Department Of Health And Human Services | Infectious dengue 2 virus pdk-53 as quadravalent vaccine |
| NZ337522A (en) | 1997-02-28 | 2001-02-23 | St | Chimeric flavivirus incorporating yellow fever virus modified such that a prM-E protein of a second flavivirus is expressed, and vaccines for flavivruses |
| AU9794198A (en) | 1997-10-08 | 1999-04-27 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Chimeric vaccine against tick-borne encephalitis virus |
| DE29810020U1 (de) | 1998-06-04 | 1998-09-24 | Siemens AG, 80333 München | Kunststoffbehälter zur Tieftemperaturlagerung von biologischen Materialien |
| WO1999063095A1 (en) | 1998-06-04 | 1999-12-09 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Nucleic acid vaccines for prevention of flavivirus infection |
| WO2001039802A1 (en) * | 1999-12-01 | 2001-06-07 | Oravax, Inc. | Chimeric flavivirus vaccines |
| EP1263965B1 (en) * | 2000-02-16 | 2011-09-28 | The Government of the United States of America, as represented by the Secretary, Department of Health & Human Services | Avirulent, immunogenic flavivirus chimeras |
| DK1159968T3 (da) * | 2000-05-30 | 2009-02-23 | Univ Mahidol | Attenuerede stammer af Dengue-virus og deres anvendelse i en vaccinesammensætning |
| CA2440593A1 (en) | 2001-03-12 | 2002-09-19 | Yale University | Compositions and methods comprising west nile virus polypeptides |
| ATE475706T1 (de) * | 2005-06-17 | 2010-08-15 | Sanofi Pasteur | Abgeschwächter dengue-serotyp-2-stamm |
| CA2611934C (en) * | 2005-06-17 | 2015-11-03 | Sanofi Pasteur | Dengue serotype 1 attenuated strain |
| KR20070017759A (ko) | 2005-08-08 | 2007-02-13 | 삼성전자주식회사 | 초해상 정보 저장 매체, 기록/재생 장치 및 기록/재생 방법 |
| JP5227172B2 (ja) * | 2005-08-10 | 2013-07-03 | サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー | デングウイルス感染に対するワクチン接種 |
| US7968102B2 (en) * | 2006-01-13 | 2011-06-28 | Sanofi Pasteur S.A. | Dengue chimeric viruses |
| PL2589602T3 (pl) * | 2006-08-15 | 2016-11-30 | Rozwinięcie komponentów szczepionki przeciwko wirusowi dengi | |
| CN101801996B (zh) | 2007-07-13 | 2013-06-12 | 佛罗里达州墨西哥湾海岸大学 | 优化的登革病毒进入抑制肽(dn81) |
| AU2009241354B2 (en) * | 2008-04-30 | 2014-06-12 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Chimeric West Nile/Dengue viruses |
| SG157244A1 (en) | 2008-05-15 | 2009-12-29 | Mp Biomedicals Asia Pacific Pte Ltd | Point of care test for the detection of exposure or immunity to dengue virus |
| WO2010085358A2 (en) * | 2009-01-23 | 2010-07-29 | The Board Of Regents Of The University Of Texas System | Flaviviruses expressing the prm, e, and ns1 proteins of other flaviviruses and uses thereof |
| US8968996B2 (en) | 2009-06-01 | 2015-03-03 | Takeda Vaccines, Inc. | Compositions and methods for rapid immunization against dengue virus |
| MX343172B (es) | 2009-06-01 | 2016-10-26 | Takeda Vaccines Inc | Composiciones y metodos para administracion de vacunas contra virus del dengue. |
| CN101560520A (zh) * | 2009-06-04 | 2009-10-21 | 中国疾病预防控制中心病毒病预防控制所 | 乙脑/登革嵌合病毒及其应用 |
| BRPI0904020B8 (pt) | 2009-10-01 | 2021-05-25 | Fundacao Oswaldo Cruz | composição vacinal contra o vírus da dengue, e, kit |
| EP2353609A1 (en) | 2010-02-04 | 2011-08-10 | Sanofi Pasteur | Immunization compositions and methods |
| TW201402143A (zh) | 2012-06-10 | 2014-01-16 | Inviragen Inc | 抗登革熱病毒疫苗之組成物及投藥方法 |
| US20150196631A1 (en) | 2012-07-24 | 2015-07-16 | Sanofi Pasteur | Vaccine compositions |
| PE20150356A1 (es) | 2012-07-24 | 2015-03-20 | Sanofi Pasteur | Composiciones de vacuna para la prevencion contra la infeccion por el virus del dengue |
| TW201920677A (zh) | 2012-11-08 | 2019-06-01 | 美商武田疫苗股份有限公司 | 登革熱病毒血清型４型之建構物的組成物、方法及用途 |
| US9878031B2 (en) * | 2012-12-14 | 2018-01-30 | Takeda Vaccines, Inc. | Compositions, methods of administration and uses for trivalent dengue virus formulations |
| JP6818548B2 (ja) | 2013-03-15 | 2021-01-20 | タケダ ワクチン, インコーポレイテッドTakeda Vaccines, Inc. | ワクチンにおけるデングウイルスキメラ構築物に関する組成物および方法 |
| TWI852899B (zh) | 2014-09-02 | 2024-08-21 | 法商賽諾菲巴斯德公司 | 疫苗組合物 |
| WO2017005654A1 (en) | 2015-07-03 | 2017-01-12 | Sanofi Pasteur | Concomitant dengue, diphtheria, tetanus, whooping cough (pertussis), polio, and haemophilus influenzae type b vaccination. |
| US10857222B2 (en) | 2015-07-03 | 2020-12-08 | Sanofi Pasteur | Concomitant dengue and yellow fever vaccination |
| US10004795B2 (en) | 2015-09-08 | 2018-06-26 | Fundacao Butantan | Process for preparing an attenuated tetravalent dengue vaccine |
| KR102611235B1 (ko) | 2016-04-13 | 2023-12-08 | 다케다 백신즈 인코포레이티드 | 어린이 및 젊은 성인에서 뎅기 바이러스에 대한 백신접종 조성물 및 방법 |
| SG10201607778XA (en) | 2016-09-16 | 2018-04-27 | Chugai Pharmaceutical Co Ltd | Anti-Dengue Virus Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use |
| CR20200212A (es) | 2017-10-16 | 2020-07-17 | Serum Institute Of India Pvt Ltd | Composiciones de vacuna estables que comprenden inter alia un flavivirus recombinante vivo atenuado y proceso para la preparación de las misma |
| PE20211545A1 (es) | 2018-09-05 | 2021-08-16 | Takeda Vaccines Inc | Dosis unitaria de vacuna contra el dengue y administracion de esta |
| US11464815B2 (en) | 2018-09-05 | 2022-10-11 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
| EP3892737A1 (en) | 2020-04-09 | 2021-10-13 | Takeda Vaccines, Inc. | Qualitative and quantitative determination of single virus haplotypes in complex samples |
-
2014
- 2014-03-12 JP JP2016501585A patent/JP6818548B2/ja active Active
- 2014-03-12 AU AU2014235476A patent/AU2014235476B2/en active Active
- 2014-03-12 ES ES20154012T patent/ES2933970T3/es active Active
- 2014-03-12 PT PT191684752T patent/PT3539565T/pt unknown
- 2014-03-12 PE PE2015001953A patent/PE20160027A1/es unknown
- 2014-03-12 KR KR1020257006481A patent/KR20250033325A/ko active Pending
- 2014-03-12 MX MX2015012893A patent/MX374519B/es active IP Right Grant
- 2014-03-12 SG SG10201913435TA patent/SG10201913435TA/en unknown
- 2014-03-12 CN CN201480028001.5A patent/CN105451763B/zh active Active
- 2014-03-12 KR KR1020227013084A patent/KR102626270B1/ko active Active
- 2014-03-12 EP EP22182269.5A patent/EP4129330B1/en active Active
- 2014-03-12 PE PE2021000217A patent/PE20211814A1/es unknown
- 2014-03-12 SI SI201432055T patent/SI4129330T1/sl unknown
- 2014-03-12 CA CA3166063A patent/CA3166063A1/en active Pending
- 2014-03-12 PH PH1/2015/502120A patent/PH12015502120B1/en unknown
- 2014-03-12 CA CA3177572A patent/CA3177572A1/en active Pending
- 2014-03-12 EP EP14722014.9A patent/EP2968516B1/en active Active
- 2014-03-12 LT LTEP22182269.5T patent/LT4129330T/lt unknown
- 2014-03-12 ES ES22182269T patent/ES2965652T3/es active Active
- 2014-03-12 CN CN202110718694.2A patent/CN113637693B/zh active Active
- 2014-03-12 SG SG10201913387XA patent/SG10201913387XA/en unknown
- 2014-03-12 NZ NZ630869A patent/NZ630869A/en unknown
- 2014-03-12 HU HUE19168475A patent/HUE061507T2/hu unknown
- 2014-03-12 KR KR1020247001384A patent/KR102775714B1/ko active Active
- 2014-03-12 CA CA3177574A patent/CA3177574A1/en active Pending
- 2014-03-12 CN CN202110718703.8A patent/CN113637694B/zh active Active
- 2014-03-12 CN CN202110723336.0A patent/CN113637086B/zh active Active
- 2014-03-12 FI FIEP19168475.2T patent/FI3539565T3/fi active
- 2014-03-12 WO PCT/US2014/024603 patent/WO2014150939A2/en not_active Ceased
- 2014-03-12 KR KR1020157029897A patent/KR102389908B1/ko active Active
- 2014-03-12 SG SG11201507460PA patent/SG11201507460PA/en unknown
- 2014-03-12 CN CN202010617988.1A patent/CN111778263B/zh active Active
- 2014-03-12 MY MYPI2015002317A patent/MY187796A/en unknown
- 2014-03-12 EP EP22204593.2A patent/EP4183411A1/en active Pending
- 2014-03-12 PL PL19168475.2T patent/PL3539565T3/pl unknown
- 2014-03-12 EP EP19168475.2A patent/EP3539565B1/en active Active
- 2014-03-12 HR HRP20231581TT patent/HRP20231581T1/hr unknown
- 2014-03-12 DK DK22182269.5T patent/DK4129330T5/da active
- 2014-03-12 EP EP20154012.7A patent/EP3689374B1/en active Active
- 2014-03-13 US US14/209,808 patent/US9783579B2/en active Active
- 2014-03-14 TW TW108114540A patent/TWI726312B/zh active
- 2014-03-14 TW TW103109624A patent/TWI733646B/zh active
- 2014-03-14 TW TW110111747A patent/TWI894248B/zh active
- 2014-03-17 AR ARP140101223A patent/AR095598A1/es unknown
- 2014-03-17 UY UY35489A patent/UY35489A/es active IP Right Grant
-
2015
- 2015-09-11 DO DO2015000232A patent/DOP2015000232A/es unknown
- 2015-09-14 MX MX2019003602A patent/MX2019003602A/es unknown
- 2015-09-14 MX MX2023000353A patent/MX2023000353A/es unknown
- 2015-09-14 MX MX2023000354A patent/MX2023000354A/es unknown
- 2015-09-14 MX MX2023000349A patent/MX2023000349A/es unknown
- 2015-10-15 CR CR20150569A patent/CR20150569A/es unknown
-
2017
- 2017-04-20 US US15/492,981 patent/US10449231B2/en active Active
-
2019
- 2019-06-05 JP JP2019105307A patent/JP7050031B2/ja active Active
- 2019-08-16 AU AU2019216724A patent/AU2019216724C1/en active Active
- 2019-09-05 US US16/561,755 patent/US20200061151A1/en not_active Abandoned
-
2021
- 2021-09-17 US US17/478,537 patent/US12186363B2/en active Active
- 2021-10-06 AR ARP210102772A patent/AR123702A2/es unknown
-
2022
- 2022-12-12 US US18/064,775 patent/US11931399B2/en active Active
- 2022-12-16 FR FR22C1064C patent/FR22C1064I2/fr active Active
-
2023
- 2023-02-24 EC ECSENADI202313715A patent/ECSP23013715A/es unknown
- 2023-03-08 NL NL301223C patent/NL301223I2/nl unknown
- 2023-06-20 HU HUS2300022C patent/HUS2300022I1/hu unknown
- 2023-06-27 FI FIC20230021C patent/FIC20230021I1/fi unknown
- 2023-07-04 NO NO2023026C patent/NO2023026I1/no unknown
-
2024
- 2024-02-28 AR ARP240100498A patent/AR132009A2/es unknown
- 2024-03-05 LT LTPA2024503C patent/LTPA2024503I1/lt unknown
- 2024-07-10 US US18/768,774 patent/US20250018006A1/en active Pending
- 2024-07-16 AR ARP240101841A patent/AR133264A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016513970A5 (cg-RX-API-DMAC7.html) | ||
| JP2016501015A5 (ja) | デングウイルス血清型４（ｄｅｎ−４）構築物に関する組成物、方法および使用 | |
| AR132009A2 (es) | Moléculas de polinucleótido y de polipéptido, virus de dengue, composiciones, vector y célula | |
| US8088391B2 (en) | West nile virus vaccine | |
| JP6486827B2 (ja) | デングウイルス血清型４（ｄｅｎ−４）構築物に関する核酸分子、組成物および使用 | |
| CA2650591C (en) | Methods for the treatment of flavivirus infection, molecules and uses thereof | |
| HUP0002139A2 (hu) | Kiméra flavivírus-vakcinák | |
| JP2019511533A5 (cg-RX-API-DMAC7.html) | ||
| JP2008520187A5 (cg-RX-API-DMAC7.html) | ||
| US9878031B2 (en) | Compositions, methods of administration and uses for trivalent dengue virus formulations | |
| CA2584228A1 (en) | Vaccines against japanese encephalitis virus and west nile virus | |
| AU2008203442B2 (en) | Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus | |
| CA2622827C (en) | Pharmaceutical compound capable of inducing immune protective response against dengue virus having the capsid protein of the dengue virus | |
| CN101970467A (zh) | 用作疫苗的在衣壳蛋白中包含缺失的黄病毒科突变体 | |
| AU2019203166B2 (en) | Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus | |
| TH170668A (th) | องค์ประกอบ และวิธีการสำหรับชุดโครงสร้างไคมีริกไวรัสเด็งกีในวัคซีน | |
| HK1083192B (en) | West nile virus vaccine |